SCHEMBL6505950

SCHEMBL6505950

Fn1ccc2cccc(Br)c21

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
BACE1 P56817 1/20 0.31
NOS1 P29475 1/20 0.31
MAPT P10636 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178459 0.74 CDK4 (0.43) SLC6A2SLC6A4BACE1NOS1CA12
SCHEMBL6030394 0.69 CYP19A1 (0.45) SLC6A2SLC6A4
SCHEMBL22955613 0.69 SLC6A2 (0.33) SLC6A2SLC6A4
SCHEMBL15741285 0.69 BIRC5 (0.38) SLC6A2SLC6A4MAPT
SCHEMBL4082423 0.69 SLC6A2 (0.44) SLC6A2SLC6A4
SCHEMBL29022361 0.67 RPS6KA5 (0.41) MAPT
SCHEMBL24143785 0.66 HTR2A (0.46) SLC6A2SLC6A4BACE1
SCHEMBL1395936 0.66 ALDH1A1 (0.37) SLC6A2SLC6A4MAPT
SCHEMBL4943939 0.66 APP (0.52)
SCHEMBL22320209 0.65 SLC6A2 (0.41) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002004440-A9 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-11-03 WO disclosed
EP-1299382-A4 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2004-02-11 EP disclosed
EP-1299382-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-04-09 EP disclosed
WO-2002004440-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-01-17 WO disclosed